VanEck Vectors Backtesting

VanEck Vectors Biotech ETF -- USA Etf  

USD 114.96  0.08  0.0695%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of VanEck Vectors Biotech ETF and determine expected loss or profit from investing in VanEck Vectors over given investment horizon. Check also VanEck Vectors Hype Analysis, VanEck Vectors Correlation, Portfolio Optimization, VanEck Vectors Volatility as well as analyze VanEck Vectors Alpha and Beta and VanEck Vectors Performance.
 Time Horizon     30 Days    Login   to change
SymbolX
Backtest

VanEck Vectors 'What if' Analysis

February 24, 2018
0.00
No Change 0.00  0.0%
In 2 months and 2 days
April 25, 2018
0.00
If you would invest  0.00  in VanEck Vectors on February 24, 2018 and sell it all today you would earn a total of 0.00 from holding VanEck Vectors Biotech ETF or generate 0.0% return on investment in VanEck Vectors over 60 days. VanEck Vectors is related to or competes with Financial Select, Technology Select, Energy Select, Vanguard Information, Health Care, Consumer Discret, and INDUSTRIAL SPDR. The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of t...

VanEck Vectors Upside/Downside Indicators

Information Ratio0.060169
Maximum Drawdown6.18
Value At Risk2.47
Potential Upside2.21
  

VanEck Vectors Market Premium Indicators

Risk Adjusted Performance0.13
Jensen Alpha0.12
Total Risk Alpha0.092937
Treynor Ratio1.05

VanEck Vectors Biotech Backtested Returns

Macroaxis considers VanEck Vectors to be not too risky. VanEck Vectors Biotech owns Efficiency Ratio (i.e. Sharpe Ratio) of -0.1252 which indicates VanEck Vectors Biotech had -0.1252% of return per unit of risk over the last 2 months. Macroaxis philosophy towards measuring risk of any etf is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. VanEck Vectors Biotech ETF exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to validate VanEck Vectors Coefficient Of Variation of 1,332 and Risk Adjusted Performance of 0.13 to confirm risk estimate we provide. The entity has beta of 0.116 which indicates as returns on market increase, VanEck Vectors returns are expected to increase less than the market. However during bear market, the loss on holding VanEck Vectors will be expected to be smaller as well.. Even though it is essential to pay attention to VanEck Vectors Biotech current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. VanEck Vectors Biotech ETF exposes twenty-one different technical indicators which can help you to evaluate its performance.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.02) 

Very weak reverse predictability

VanEck Vectors Biotech ETF has very weak reverse predictability. Overlapping area represents the amount of predictability between VanEck Vectors time series from February 24, 2018 to March 26, 2018 and March 26, 2018 to April 25, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VanEck Vectors Biotech price movement. The serial correlation of -0.02 indicates that only 2.0% of current VanEck Vectors price fluctuation can be explain by its past prices. Given that VanEck Vectors Biotech ETF has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of VanEck Vectors for similar time interval.
Correlation Coefficient -0.02
Spearman Rank Test -0.3
Price Variance 2.62
Lagged Price Variance 7.48

VanEck Vectors Biotech lagged returns against current returns

 Current and Lagged Values 
      Timeline 

VanEck Vectors regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

VanEck Vectors Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - BBH

VanEck Vectors Biotech Investor Sentiment
Greater number of Macroaxis users are currently bullish on VanEck Vectors Biotech ETF. What is your outlook on investing in VanEck Vectors Biotech ETF? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

BATS Exchange Efficient Frontier

Diversify in USA Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
Diversify Portfolios
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify Portfolios
Check also VanEck Vectors Hype Analysis, VanEck Vectors Correlation, Portfolio Optimization, VanEck Vectors Volatility as well as analyze VanEck Vectors Alpha and Beta and VanEck Vectors Performance. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.